2026-01-15 - Analysis Report
**LINDE PLC Stock Report**
==========================

### Company Overview
* Linde PLC is a leading technology company in the global gases industry.

### Return Rate Comparison
* **Linde PLC (LIN)**: Cumulative return of 57.53%
* **S&P 500 (VOO)**: Cumulative return of 92.89%
* **Divergence (max: 52.60, min: -51.50, current: -35.40, relative divergence: 15.50%)**
* The divergence indicates that LIN has not kept pace with the S&P 500's growth, but is still within the moderate range of past data.

### Alpha, Beta Analysis
| **Year** | **CAGR** | **MDD** | **Alpha** | **Beta** | **Cap(B)** |
|---------|---------|--------|----------|---------|------------|
| 2016-2018| 11.0%   | 13.9%  | 7.0%     | 0.9     | 73.2B      |
| 2017-2019| 35.0%   | 13.9%  | 18.0%    | 0.9     | 99.8B      |
| 2018-2020| 10.0%   | 16.0%  | -11.0%   | 1.0     | 123.6B     |
| 2019-2021| 58.0%   | 16.0%  | 15.0%    | 1.0     | 162.4B     |
| 2020-2022| 34.0%   | 17.4%  | 36.0%    | 1.0     | 152.9B     |
| 2021-2023| 39.0%   | 17.4%  | 38.0%    | 0.9     | 192.6B     |
| 2022-2024| 5.0%    | 17.4%  | -15.0%   | 0.8     | 196.3B     |
| 2023-2025| -12.0%  | 22.5%  | -74.0%   | 0.6     | 199.9B     |

### Stock Price Fluctuations
* Close: $439.98
* 5-day SMA: $442.06
* 20-day SMA: $430.48
* 60-day SMA: $422.93
* **Note:** The 5-day SMA is currently above the close price, while the 20-day and 60-day SMAs are below, indicating a short-term trend.

### Indicators and Analysis
* **Market Risk Indicator (MRI)**: 0.70 (High Investment Recommended)
* **RSI**: 72.06
* **PPO**: 0.34
* **Hybrid Signal**: Buy (Cash 0%)
* **Risk Level**: Medium (MRI 0.70)
* **Recent (20 days) relative divergence change**: 1.50 (+): improving
* **7-day Rank change**: -28 (-): rank down
* **7-day Dynamic Expected Return change**: -28.90 (-): worsening
* **Expected Return (%)**: 145.50%

### Recent News & Events
* [2026-01-14] Hereâ€™s What Dragged Linde plc (LIN) in Q4 - Yahoo Finance
* [2026-01-02] Why Linde Stock May Be More Vulnerable Than It Appears - Benzinga
* [2026-01-12] How Investors May Respond To Linde (LIN) Upcoming Q4 2025 Earnings And European Margin Signals - simplywall.st
* [2025-12-20] How Low Can Linde Stock Really Go? - Trefis
* [2026-01-08] Linde: Built To Compound For Decades (NASDAQ:LIN) - Seeking Alpha
* [2025-12-11] $LIN stock is up 2% today. Here's what we see in our data. - Quiver Quantitative

### Analyst Opinions
* **Analyst Consensus:**
	+ Key: Strong_Buy
	+ Mean (1=StrongBuy~5=Sell): 1.50 (~Buy)
	+ Opinions: 24
	+ Target Price (avg/high/low): 503.21 / 565.00 / 381.00

### Recent Earnings Analysis
| **Date** | **EPS** | **Revenue** |
|---------|--------|-------------|
| 2025-10-31| 4.11   | $8.62B      |
| 2025-08-01| 3.75   | $8.49B      |
| 2025-05-01| 3.53   | $8.11B      |
| 2024-10-31| 3.24   | $8.36B      |
| 2025-10-31| 3.24   | $8.36B      |

### Financial Information
**Revenue and Profitability:**
| **Quarter** | **Revenue** | **Profit Margin** |
|-------------|-------------|------------------|
| 2025-09-30  | $8.62B      | 49.17%            |
| 2025-06-30  | $8.49B      | 49.31%            |
| 2025-03-31  | $8.11B      | 48.75%            |
| 2024-12-31  | $8.28B      | 47.84%            |
| 2024-09-30  | $8.36B      | 47.87%            |

**Capital and Profitability:**
| **Quarter** | **Equity** | **ROE** |
|-------------|-----------|--------|
| 2025-09-30  | $38.62B   | 5.00%  |
| 2025-06-30  | $38.52B   | 4.59%  |
| 2025-03-31  | $38.03B   | 4.40%  |
| 2024-12-31  | $38.09B   | 4.53%  |
| 2024-09-30  | $39.17B   | 3.96%  |

**Overall Analysis:**
* Linde PLC has a moderate divergence with the S&P 500's growth, indicating a potential for long-term investment.
* The stock price has recently experienced a short-term trend of decline, but is showing signs of improvement.
* The hybrid signal is indicating a buy, with a risk level of medium.
* The expected return is estimated to be 145.50%.
* Recent news and events suggest potential vulnerability and upcoming earnings and margin signals.
* Analyst opinions indicate a strong buy with a target price of 503.21.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.